Skip to main content
Clinical Trials/NCT03122483
NCT03122483
Completed
Not Applicable

Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)

Beckman Coulter, Inc.3 sites in 1 country250 target enrollmentJanuary 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obstructive Sleep Apnea
Sponsor
Beckman Coulter, Inc.
Enrollment
250
Locations
3
Primary Endpoint
Identification of OSA in high-risk individuals
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This multicenter prospective trial will evaluate the association between obstructive sleep apnea (OSA) and blood biomarkers in a representative population of consecutively enrolled symptomatic patients with a clinical suspicion of OSA.

Registry
clinicaltrials.gov
Start Date
January 2016
End Date
July 14, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Written Informed Consent
  • 18-70 years old
  • Presentation with symptoms suggestive of obstructive sleep apnea
  • Diagnostic sleep study
  • Blood draw

Exclusion Criteria

  • Prior (within past year) or current therapy for sleep apnea
  • Use of opioid pain medication, steroids or allopurinol (within past 30 days)
  • Use of chronic anti-inflammatory drugs (within past 7 days)
  • Active cancer under current treatment or monitoring

Outcomes

Primary Outcomes

Identification of OSA in high-risk individuals

Time Frame: 1 day

Identification of OSA in high-risk individuals

Study Sites (3)

Loading locations...

Similar Trials